Literature DB >> 632147

Combined radiotherapy--chemotherapy of Lewis lung carcinoma.

G G Steel, R P Hill, M J Peckham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 632147     DOI： 10.1016/0360-3016(78)90114-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  10 in total

1.  Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.

Authors:  B A Teicher; S D Bernal; S A Holden; K N Cathcart
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

2.  CAI: effects on cytotoxic therapies in vitro and in vivo.

Authors:  B A Teicher; S A Holden; Y N Chen; G Ara; T T Korbut; D Northey
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.

Authors:  B A Teicher; E A Sotomayor; Z D Huang; G Ara; S Holden; V Khandekar; Y N Chen
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

4.  Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo.

Authors:  E A Sotomayor; B A Teicher; G N Schwartz; S A Holden; K Menon; T S Herman; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Cyclooxygenase and lipoxygenase inhibitors as modulators of cancer therapies.

Authors:  B A Teicher; T T Korbut; K Menon; S A Holden; G Ara
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  Efficacy and safety of concurrent chemoradiotherapy in ECOG 2 patients with locally advanced non-small-cell lung cancer: a subgroup analysis of a randomized phase III trial.

Authors:  Nan Bi; Lipin Liu; Jun Liang; Shixiu Wu; Ming Chen; Changxing Lv; Lujun Zhao; Anhui Shi; Wei Jiang; Yaping Xu; Zongmei Zhou; Jingbo Wang; Wenqing Wang; Dongfu Chen; Zhouguang Hui; Jima Lv; Hongxing Zhang; Qinfu Feng; Zefen Xiao; Xin Wang; Tao Zhang; Weibo Yin; Junling Li; Jie He; Luhua Wang
Journal:  BMC Cancer       Date:  2020-04-06       Impact factor: 4.430

7.  Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice.

Authors:  J E Pedersen; M R Smith; R D Bugden; M J Peckham
Journal:  Br J Cancer       Date:  1979-04       Impact factor: 7.640

8.  Repopulation of gamma-irradiated Lewis lung carcinoma by malignant cells and host macrophage progenitors.

Authors:  T C Stephens; G A Currie; J H Peacock
Journal:  Br J Cancer       Date:  1978-11       Impact factor: 7.640

9.  Identification of a subpopulation of MeCCNU resistant cells in previously untreated Lewis lung tumours.

Authors:  T C Stephens; K Adams; J H Peacock
Journal:  Br J Cancer       Date:  1984-07       Impact factor: 7.640

10.  Tracheoesophageal fistula associated with bevacizumab after thoracic radiotherapy in non-small cell lung cancer: A case report.

Authors:  Tao Zhang; Yin Yang; Guowei Cheng; Ping Chen; Nan Bi
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.